CONWAY MARSH GARRETT TECHNOLOGIES LIMITED

Financial Health Score: C+ (Stable but Requiring Intensive Care)

The score reflects a business with a strong underlying constitution and excellent family support, but one that has recently suffered a severe operational hemorrhage. While the balance sheet remains solvent and liquidity is present, the massive loss suffered in the latest financial year is a critical symptom that requires immediate attention. Without the financial life support provided by its parent company, the outlook would be significantly more precarious.

1. Key Vital Signs

• Blood Pressure (Liquidity & Cash): Healthy. The current ratio stands at a robust 3.33 (£1.57M current assets / £473k current liabilities). Cash on hand has improved from £209,991 to £231,958. The company is not struggling to meet its immediate financial obligations.
• Weight Loss (Retained Earnings): Critical. The patient has experienced severe weight loss. Retained earnings dropped drastically from £1,818,136 to £665,314. Factoring in the £500,000 capital injection (increase in share capital and share premium), the company suffered an operating loss of approximately £1.15 million for the year. This is a significant hemorrhage of value.
• Cholesterol (Inventory Build-up): Elevated. Inventories have increased by roughly 33%, rising from £483,297 to £645,382. While this could be strategic stockpiling, it represents cash tied up in the warehouse, potentially blocking healthy cash flow arteries if not converted to sales efficiently.
• Immune System (Parental Support): Active. The financial statements explicitly note the company made a loss but is deemed a going concern due to a "letter of financial support from its parent company." Conway Marsh Garrett Holdings Limited owns more than 75% of the shares, acting as a vital safety net.

2. Symptoms Analysis

The most glaring symptom in this diagnosis is the dramatic drop in net assets and retained earnings. A £1.15 million loss in a company of this size indicates a major adverse event—likely a significant write-down, a large contract failure, or severe margin compression in their manufacturing operations (Metal Injection Moulding, 3D Printing, etc.).

However, the symptoms present a paradox. While the P&L (income statement) shows the patient bleeding out, the balance sheet (statement of financial position) shows a surprisingly stable pulse. Trade receivables dropped significantly (from £979k to £702k), suggesting the company was successful in collecting cash from customers. Furthermore, the parent company stepped in with a £500,000 capital transfusion via share capital and share premium, which helps replace the lost equity, keeping the patient's "blood volume" at functional levels.

3. Diagnosis

Diagnosis: Acute Operational Hemorrhage with Parental Life Support

The business is suffering from a severe operational shock, as evidenced by the massive loss of retained earnings. A loss of this magnitude typically signals either a major impairment/write-off of assets or a fundamental breakdown in profitability.

Yet, the patient is not in cardiac arrest. The going concern note is the equivalent of a "Do Not Resuscitate" (DNR) override—the parent company has guaranteed the patient's heartbeat for the foreseeable future. The company's underlying liquidity is fine; it can pay its bills. The diagnosis is therefore one of a subsidiary undergoing a painful restructuring or absorbing a major financial hit, safely housed within a larger corporate group that can absorb the shock.

4. Recommendations

1. Stop the Bleeding (Cost & Margin Control): The most urgent priority is to identify the root cause of the £1.15 million loss. Management must perform a surgical review of cost structures and contract profitability to ensure this level of loss is not repeated in the next fiscal year.
2. Clear the Arteries (Inventory Management): With inventory levels rising by a third, the business must focus on converting this stock back into cash. Implement targeted sales initiatives or reassess production volumes to prevent cash from being trapped in unsold goods.
3. Formalize the Transfusion (Funding Structure): While a letter of financial support from the parent is sufficient for the going concern basis, it is a temporary tourniquet. The company should consider formalizing this support through long-term director loans or more permanent equity injections to provide a more stable capital structure.
4. Monitor the Vitals (Cash Flow Forecasting): Given the volatility, the directors must maintain a rigorous, rolling 13-week cash flow forecast to ensure that the healthy current ratio does not deteriorate unexpectedly.